Probing the genetic basis for thyrotropin receptor antibodies and hyperthyroidism in immunized CXB recombinant inbred mice

Endocrinology

Volumn 147, Issue 6, 2006, Pages 2789-2800

  Aliesky, Holly A ^a   Pichurin, Pavel N ^a   Chen, Chun Rong ^a   Williams, Robert W ^b   Rapoport, Basil ^a   McLachlan, Sandra M ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN SUBUNIT; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CHROMOSOME 10; CHROMOSOME 17; CHROMOSOME 19; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE LOCUS; GENE MAPPING; GOITER; GRAVES DISEASE; HORMONE BINDING; HYPERTHYROIDISM; IMMUNIZATION; INBRED STRAIN; LINKAGE ANALYSIS; MAJOR HISTOCOMPATIBILITY COMPLEX; MATING; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROGENY;

ADENOVIRIDAE; ANIMALS; ANTIBODY FORMATION; AUTOANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HYPERTHYROIDISM; LINKAGE (GENETICS); MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PROTEIN SUBUNITS; RECEPTORS, THYROTROPIN; RECOMBINATION, GENETIC; THYROXINE;

EID: 33646798040     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-0160     Document Type: Article

References (44)

1. McLachlan SM, Nagayama Y, Rapoport B 2005 Insight into Graves' hyperthyroidism from animal models. Endocr Rev 26:800-832
2. Nagayama Y, Kita-Furuyama M, Ando T, Nakao K, Mizuguchi H, Hayakawa T, Eguchi K, Niwa M 2002 A novel murine model of Graves' hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor. J Immunol 168:2789-2794
3. Chen C-R, Pichurin P, Nagayama Y, Latrofa F, Rapoport B, McLachlan SM 2003 The thyrotropin receptor autoantigen in Graves' disease is the culprit as well as the victim. JClin Invest 111:1897-1904
4. Chen C-R, Pichurin P, Chazenbalk GD, Aliesky H, Nagayama Y, McLachlan SM, Rapoport B 2004 Low-dose immunization with adenovirus expressing the thyroid-stimulating hormone receptor A-subunit deviates the antibody response toward that of autoantibodies in human Graves' disease. Endocrinology 145:228-233
5. Chen CR, Aliesky H, Pichurin PN, Nagayama Y, McLachlan SM, Rapoport B 2004 Susceptibility rather than resistance to hyperthyroidism is dominant in a thyrotropin receptor adenovirus-induced animal model of Graves' disease as revealed by BALB/c-C57BL/6 hybrid mice. Endocrinology 145:4927-4933
6. Nagayama Y, McLachlan SM, Rapoport B, Niwa M 2003 A major role for non-MHC genes, but not for micro-organisms, in a novel model of Graves' hyperthyroidism. Thyroid 13:233-238
7. Shimojo N, Kohno Y, Yamaguchi K-I, Kikuoka S-I, Hoshioka A, Niimi H, Hirai A, Tamura Y, Saito Y, Kohn LD, Tahara K 1996 Induction of Graves-like disease in mice by immunization with fibroblasts transfected with the thyrotropin repector and a class II molecule. Proc Natl Acad Sci USA 93:11074-11079
8. Yamaguchi K-I, Shimojo N, Kikuoka S, Hoshioka A, Hirai A, Tahara K, Kohn LD, Kohno Y, Niimi H 1997 Genetic control of anti-thyrotropin receptor antibody generation in H-2k mice immunized with thyrotropin receptor-transfected fibroblasts. J Clin Endocrinol Metab 82:4266-4269
9. Bailey DW 1971 Recombinant-inbred strains. An aid to finding identity, linkage, and function of histocompatibility and other genes. Transplantation 11:325-327
10. 1997 Handbook on genetically standardized Jax mice. 5th ed. Bar Harbor, ME: The Jackson Laboratory
11. Williams RW, Gu L, Qi S, Lu L 2001 The genetic structure of recombinant inbred mice: high-resolution consensus maps for complex trait analysis. Genome Biol 2:Research0046.1-0046.18
12. Airey DC, Lu L, Williams RW 2001 Genetic control of the mouse cerebellum: identification of quantitative trait loci modulating size and architecture. J Neurosci 21:5099-5109
13. Scalzo AA, Fitzgerald NA, Wallace CR, Gibbons AE, Smart YC, Burton RC, Shellam GR 1992 The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells. J Immunol 149:581-589
14. Mountz JD, Yang P, Wu Q, Zhou J, Tousson A, Fitzgerald A, Allen J, Wang X, Cartner S, Grizzle WE, Yi N, Lu L, Williams RW, Hsu HC 2005 Genetic segregation of spontaneous erosive arthritis and generalized autoimmune disease in the BXD2 recombinant inbred strain of mice. Scand J Immunol 61:128-138
15. Mittereder N, March KL, Trapnell BC 1996 Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J Virol 70:7498-7509
16. Chazenbalk GD, Jaume JC, McLachlan SM, Rapoport B 1997 Engineering the human thyrotropin receptor ectodomain from a non-secreted form to a secreted, highly immunoreactive glycoprotein that neutralizes autoantibodies in Graves' patients' sera. J Biol Chem 272:18959-18965
17. Chazenbalk GD, Wang Y, Guo J, Hutchison JS, Segal D, Jaume JC, McLachlan SM, Rapoport B 1999 A mouse monoclonal antibody to a thyrotropin receptor ectodomain variant provides insight into the exquisite antigenic conformational requirement, epitopes and in vivo concentration of human autoantibodies. J Clin Endocrinol Metab 84:702-710
18. Bailey DW 1982 How pure are inbred strains of mice? Immunol Today 3:210-214
19. Muehlberg T, Gilbert JA, Rao PV, McGregor AM, Banga JP 2004 Dynamics of thyroid-stimulating and -blocking antibodies to the thyrotropin receptor in a murine model of Graves' disease. Endocrinology 145:1539-1545
20. Ban Y, Tomer Y 2005 Susceptibility genes in thyroid autoimmunity. Clin Dev Immunol 12:47-58
21. Kong YM 2004 Experimental models for autoimmune thyroid disease: recent developments. In: Volpe R, ed. Contemporary endocrinology: autoimmune endocrinopathies. Totawa, NJ: Humana Press; 91-111
22. Farid NR, Stone E, Johnson G 1980 Graves' disease and HLA: clinical and epidemiologic associations. Clin Endocrinol 15:535-544
23. Simmonds MJ, Howson JM, Heward JM, Cordell HJ, Foxall H, Carr-Smith J, Gibson SM, Walker N, Tomer Y, Franklyn JA, Todd JA, Gough SC 2005 Regression mapping of association between the human leukocyte antigen region and Graves disease. Am J Hum Genet 76:157-163
24. Roman SH, Greenberg D, Rubinstein P, Wallenstein S, Davies TF 1992 Genetics of autoimmune thyroid disease: lack of evidence for linkage to HLA within families. J Clin Endocrinol Metab 74:496-503
25. McLachlan SM 1993 The genetic basis of autoimmune thyroid disease: time to focus on chromosomal loci other than the major histocompatibility complex (HLA in man). J Clin Endocrinol Metab 77:605A-605C
26. Inoue D, Sato K, Sugawa H, Akamizu T, Maeda M, Inoko H, Tsuji K, Mori T 1993 Apparent genetic difference between hypothyroid patients with blocking-type thyrotropin receptor antibody and those without, as shown by restriction fragment length polymorphism analyses of HLA-DP loci. J Clin Endocrinol Metab 77:606-610
27. Cho BY, Chung JH, Shong YK, Chang YB, Han H, Lee J-B, Lee HK, Koh C-S 1993 A strong association between thyrotropin receptor-blocking antibodypositive atrophic autoimmune thyroiditis and HLA-DR8 and HLA-DQB1*0302 in Koreans. J Clin Endocrinol Metab 77:611-615
28. Tomer Y, Barbesino G, Greenberg DA, Concepcion E, Davies TF 1999 Mapping the major susceptibility loci for familial Graves' and Hashimoto's diseases: evidence for genetic heterogeneity and gene interactions. J Clin Endocrinol Metab 84:4656-4664
29. Cha Y, Holland SM, August JT 1990 The cDNA sequence of mouse LAMP-2. Evidence for two classes of lysosomal membrane glycoproteins. J Biol Chem 265:5008-5013
30. Daugas E, Nochy D, Ravagnan L, Loeffler M, Susin SA, Zamzami N, Kroemer G 2000 Apoptosis-inducing factor (AIF): a ubiquitous mitochondrial oxidoreductase involved in apoptosis. FEBS Lett 476:118-123
31. Barbesino G, Tomer Y, Concepcion E, Davies TF, Greenberg D 1998 Linkage analysis of candidate genes in autoimmune thyroid disease: II. Selected gender-related genes and the X-chromosome. J Clin Endocrinol Metab 83:3290-3295
32. Imrie H, Vaidya B, Perros P, Kelly WF, Toft AD, Young ET, Kendall-Taylor P, Pearce SH 2001 Evidence for a Graves' disease susceptibility locus at chromosome Xp11 in a United Kingdom population. J Clin Endocrinol Metab 86:626-630
33. Tomer Y, Ban Y, Concepcion E, Barbesino G, Villanueva R, Greenberg DA, Davies TF 2003 Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families. Am J Hum Genet 73:736-747
34. Taylor JC, Gough SC, Hunt PJ, Brix TH, Chatterjee K, Connell JM, Franklyn JA, Hegedus L, Robinson BG, Wiersinga WM, Wass JA, Zabaneh D, Mackay I, Weetman AP 2006 A genome-wide screen in 1119 relative pairs with autoimmune thyroid disease. J Clin Endocrinol Metab 91:646-653
35. Yanagawa T, Hidaka Y, Guimaraes V, Soliman M, DeGroot LJ 1995 CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. J Clin Endocrinol Metab 80:41-45
36. Tomer Y, Greenberg DA, Concepcion E, Davies TF 2002 A single C/T nucleotide polymorphism in the promoter region of the CD40 gene confers susceptibility to Graves' disease. Thyroid 12:1129-1135
37. Velaga MR, Wilson V, Jennings CE, Owen CJ, Herington S, Donaldson PT, Ball SG, James RA, Quinton R, Perros P, Pearce SH 2004 The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease. J Clin Endocrinol Metab 89:5862-5865
38. Hiratani H, Bowden DW, Ikegami S, Shirasawa S, Shimizu A, Iwatani Y, Akamizu T 2005 Multiple SNPs in intron 7 of thyrotropin receptor are associated with Graves' disease. J Clin Endocrinol Metab 90:2898-2903
39. Dechairo BM, Zabaneh D, Collins J, Brand O, Dawson GJ, Green AP, Mackay I, Franklyn JA, Connell JM, Wass JA, Wiersinga WM, Hegedus L, Brix T, Robinson BG, Hunt PJ, Weetman AP, Carey AH, Gough SC 2005 Association of the TSHR gene with Graves' disease: the first disease specific locus. Eur J Hum Genet 13:1223-1230
40. Ban Y, Greenberg DA, Concepcion E, Skrabanek L, Villanueva R, Tomer Y 2003 Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease. Proc Natl Acad Sci USA 100:15119-15124
41. Simmonds MJ, Heward JM, Carr-Smith J, Foxall H, Franklyn JA, Gough SC 2006 Contribution of single nucleotide polymorphisms within FCRL3 and MAP3K7IP2 to the pathogenesis of Graves' disease. J Clin Endocrinol Metab 91:1056-1061
42. Seyfried TN, Glaser GH, Yu RK 1984 Genetic analysis of serum thyroxine content and audiogenic seizures in recombinant inbred and congenic strains of mice. Exp Neurol 83:423-428
43. Schauder B, Schomburg L, Kohrle J, Bauer K 1994 Cloning of a cDNA encoding an ectoenzyme that degrades thyrotropin-releasing hormone. Proc Natl Acad Sci USA 91:9534-9538
44. Schomburg L, Bauer K 1995 Thyroid hormones rapidly and stringently regulate the messenger RNA levels of the thyrotropin-releasing hormone (TRH) receptor and the TRH-degrading ectoenzyme. Endocrinology 136:3480-3485